Bionoid Pharma Inc is a technology-focused company developing proprietary software solutions that leverage artificial intelligence (AI) and automation to optimize customer acquisition and audience engagement... Show more
BINP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 19 cases where BINP's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The Momentum Indicator moved above the 0 level on June 30, 2025. You may want to consider a long position or call options on BINP as a result. In of 42 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for BINP just turned positive on July 02, 2025. Looking at past instances where BINP's MACD turned positive, the stock continued to rise in of 28 cases over the following month. The odds of a continued upward trend are .
BINP moved below its 50-day moving average on June 12, 2025 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for BINP crossed bearishly below the 50-day moving average on June 13, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
The Aroon Indicator for BINP entered a downward trend on June 24, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows